01—Abstract
Summary
Summary of the 8-K filed February 26, 2025. Cited figures are marked; the original filing is the authoritative source.
Johnson & Johnson (JNJ) completed the public offering of five tranches of euro-denominated senior notes on February 26, 2025, under its effective Form S-3 shelf registration (Reg.
No. 333-269836). The total aggregate principal amount is €4.0 billion across maturities from 2029 to 2055: €600 million of 2.700%a notes due 2029, €700 million of 3.050% notes due 2033, €1.0 billion of 3.350% notes due 2037, €700 million of 3.600% notes due 2045, and €1.0 billion of 3.700% notes due 2055. The principal-weighted average coupon is roughly 3.33%.
The offering was executed through an underwriting agreement dated February 19, 2025 with Citigroup Global Markets Limited, Deutsche Bank AG (London Branch), Goldman Sachs & Co. LLC, and other underwriters. The agreement incorporates standard debt underwriting provisions previously filed on Form 8-K. The filing is primarily a disclosure of completed financing and does not report financial results, guidance, or changes in operations.
For investors, this is a routine, non-dilutive debt financing that adds to the company's long-term debt and diversifies its funding into the euro market. The filing does not disclose the net proceeds, use of proceeds, or the company's stated purpose, so those details would need to be confirmed in the prospectus supplement or subsequent filings.
02—Key points
Key Highlights
- Total euro-denominated senior notes issued: €4.0 billion across five tranches.
- Maturity ladder spans 2029 to 2055, with the 2055 notes (€1.0 billion, 3.700%) as the longest tranche.
- Coupons range from 2.700% (2029 notes) to 3.700% (2055 notes); the principal-weighted average coupon is approximately 3.33%.
- Largest tranches are €1.0 billion each: the 3.350% notes due 2037 and the 3.700% notes due 2055.
- Issued under the effective Form S-3 shelf registration (Reg. No. 333-269836); underwriting agreement dated February 19, 2025.
- Underwriters include Citigroup Global Markets Limited, Deutsche Bank AG (London Branch), and Goldman Sachs & Co. LLC.
- Filing reports no earnings, guidance, or operational changes; it is a capital markets transaction disclosure.
03—Questions
Frequently Asked Questions
How much debt did Johnson & Johnson issue in this offering?
The company issued a total of €4.0 billion in aggregate principal amount of senior notes across five tranches, due 2029, 2033, 2037, 2045, and 2055.
What interest rates do the notes carry?
The fixed coupons are 2.700% (2029 notes), 3.050% (2033 notes), 3.350% (2037 notes), 3.600% (2045 notes), and 3.700% (2055 notes). The principal-weighted average is roughly 3.33%.
Under what registration was the offering made?
The notes were sold under the company's Registration Statement on Form S-3, Reg. No. 333-269836, which is a shelf registration allowing repeated offerings without a new registration for each one.
Who underwrote the offering?
Citigroup Global Markets Limited, Deutsche Bank AG (London Branch), Goldman Sachs & Co. LLC, and several other underwriters named in the underwriting agreement dated February 19, 2025.
Does this filing say how the proceeds will be used?
No. The 8-K covers the completion of the offering and the legal documents but does not state the net proceeds or intended use. Those details would typically appear in the prospectus supplement.
04—Continue